OINDPnews


Proveris Scientific

News

Pharmascience to discontinue pms-sodium cromoglycate inhalation solution

Canadian pharma company Pharmascience has announced that it will stop manufacturing pms-sodium cromoglycate inhalation solution due to a 95% drop in demand over the past 15 years. Pharmascience now says it will sell pms-sodium cromoglycate for $24.23 per 50-nebule unit until it runs out of inventory. According to a November 19, 2021 Canadian news report, the … [Read more...] about Pharmascience to discontinue pms-sodium cromoglycate inhalation solution

Checking in with ISAM

By the ISAM board of directors As scientific leaders during a respiratory pandemic, the International Society for Aerosols in Medicine (ISAM) has been very busy over the past year, working to advance the understanding of aerosol medicine through the ISAM Journal (Journal of Aerosol Medicine and Pulmonary Drug Delivery), our 2021 Congress, a series of webinars, … [Read more...] about Checking in with ISAM

Team Consulting adds new laboratory space and re-opens to visitors

Following the lifting of government restrictions related to the COVID-19 pandemic, device design and development company Team Consulting is once again welcoming visitors to its headquarters in Cambridge, UK. Team has recently opened a new building at the Abbey Barns site, the company said, adding 5,500 sq ft of new laboratory space, workspaces, and design facilities. … [Read more...] about Team Consulting adds new laboratory space and re-opens to visitors

FDA approves Alembic’s generic formoterol fumarate inhalation solution

The FDA has approved Alembic Pharmaceuticals' ANDA for its formoterol fumarate inhalation solution, a generic of Mylan's Perforomist inhalation solution for the treatment of COPD, the company said. According to the announcement, this is the company's first US approval for an inhaled product. Alembic said that it worked with Indian contract research organization … [Read more...] about FDA approves Alembic’s generic formoterol fumarate inhalation solution

Kindeva to install new MDI manufacturing line for filling lower GWP propellants

Kindeva Drug Delivery announced that it will install a new MDI manufacturing line capable of filling either HFA-152a or HFO-1234ze, both of which have a lower global warming potential (GWP) than HFA 134a. The new line is expected to be in place by the end of 2022, and the company said that it plans to launch two MDIs formulated with the lower GWP propellants by … [Read more...] about Kindeva to install new MDI manufacturing line for filling lower GWP propellants

FDA clears IND for Phase 2 study of Tonix’s intranasal oxytocin for the prevention of migraine

According to Tonix Pharmaceuticals, the FDA has cleared the company's IND for a Phase 2 study of TNX-1900 potentiated oxytocin nasal spray for the prevention of migraine headache. Tonix acquired the rights to the intranasal oxytocin for the treatment of migraine from Trigemina in June 2020 and says that it would plan to submit an NDA under the 505(b)(2) pathway. Over … [Read more...] about FDA clears IND for Phase 2 study of Tonix’s intranasal oxytocin for the prevention of migraine

Strados Labs gets CE mark for RESP lung sounds sensor

Strados Labs announced that its RESP Smart Sensor Platform, which remotely measures and records lung sounds for use in respiratory disease treatment and clinical trials, has been granted a CE mark. According to Strados, a number of clinical trial sponsors are using measurements made by the RESP system as endpoints in studies of drugs in development for the treatment … [Read more...] about Strados Labs gets CE mark for RESP lung sounds sensor